Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

DanCann Pharma A/S Announces Exercise of Warrants for Proceeds of DKK approx. DKK 9.3 million to Strengthen the Financial Position

COPENHAGEN, Denmark, 17 January 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the “Company”), a Danish company powered by cannabinoids, hereby announce that the Company and 18 of its warrant-holders have exercised a total of 1,917,271 warrants issued pursuant to the terms set out in Schedules 6.5.1 and 7.1 of the Articles of Association.The warrant holders have exercised a total of 1,917,271 warrants issued pursuant to the terms set out in Schedules 6.5.1 and 7.1 of the Articles of Association. These warrants are exercised based on an agreement between DanCann Pharma and the

BioStock: Positive interim results from Spago Nanomedical

Lund-based company Spago Nanomedical recently announced interim results from their phase I study with SpagoPix, the tumour selective contrast agent in cancer diagnostics with magnetic resonance imaging. The results show that the candidate is safe, that it accumulates into the tumours, and that it provides clear contrast enhancement in the image analysis. Based on these results the company has decided to expand the study to new indications, in addition to breast cancer. BioStock reached out to CEO Mats Hansen for a comment.Read the interview with Spago Nanomedical's CEO Mats Hansen at

Episurf’s implants approved for sale in Malaysia

Episurf Medical (NASDAQ: EPIS B) today announces that the Medical Device Authority (MDA) in Malaysia has approved the company’s implant technologies Episealer® Knee and Episealer® Talus for the Malaysian market. The approval follows a review process. “It is exciting to see the progress of the regulatory work for Episurf’s devices towards new markets. This regulatory approval opens up the market and enables us to work with our distributor towards the next important steps in Malaysia“, says Michael Näsström, Head of Quality and Regulatory Affairs at Episurf Medical.

Wulff Group Plc´s new Chief Financial Officer

STOCK EXCHANGE RELEASE | JANUARY 17, 2022 AT 9.30 A.M. Wulff Group Plc’s current CFO and member of the Executive Board, Elina Hanén, MSc is resigning from her position. Wulff Group Plc’s new CFO and member of the Executive Board from 1 February onwards will be Atte Ailio, MSc. He will be responsible for the economic and financial management of Wulff Group. Ailio will be reporting to the company’s CEO Elina Pienimäki.  Atte Ailio has extensive experience from economic and financial management tasks in multiple sectors. His diverse experience of M&A and financing provides him with an

Jens Lindberg takes office as CEO of Medivir on January 24

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announced that Jens Lindberg will assume his position as CEO on January 24, 2022. Magnus Christensen, who has been interim CFO since the Annual General Meeting on May 5, 2021 will remain as CFO of Medivir. Jens Lindberg joins Medivir from his current position as VP Commercial at Sedana Medical, where he also served as acting CEO of the company during Q2-Q3 2021. Prior to that, during his twenty-five years at AstraZeneca, Jens held numerous roles, spanning local and global areas of responsibility. In the later years at

Mandatory notification of trade

Anooj Unarket, Board member of Otello Corporation ASA, has on behalf of certain related parties, as of 14th January 2022, acquired interests in shares of Otello Corporation ASA. The balance of Anooj Unarket and related parties’ holdings after the transaction totals 27,054,136 shares. Please refer to the attached notification of trading for further details. This information is subject to disclosure requirements in regulation EU 596/2014 article 19 number 3 and the Norwegian Securities Trading Act section 5-12.

New European patent approval for Episurf Medical

The European patent office EPO has announced its intention to grant another European patent for Episurf Medical (NASDAQ: EPIS B). The patent, entitled “Tools for assisting in osteotomy procedures, and methods for designing osteotomy tools” relates to surgical instruments in Episurf Medical’s Episealer® Talus technology for the ankle. “The patent covers Episurf’s individualised osteotomy guide, developed for optimised clinical outcomes when treating difficult to reach ankle lesions. This device is an important part of the Episealer® Talus technology”, comments Katarina Flodström, COO,

Invitation to SSAB’s year-end report 2021 briefing

SSAB invites you to a presentation of the year-end report for 2021 at 9.30am CET on Friday, January 28, 2022. The briefing will take place by combined webcast and conference call that will be webcast on SSAB’s website. The report will be published at approximately 7.30am CET on the same date.The year-end report will be presented by SSAB’s President and CEO Martin Lindqvist, and CFO Leena Craelius. The briefing will be held in English. Time of briefing: Friday, January 28, 2022 at 9.30am CET. Teleconference numbers:Sweden:                        +46 856 6426 51United Kingdom:

CapMan Nordic Property Income Fund (non-UCITS) acquires a warehouse asset close to Gothenburg further strengthening fund’s exposure to light industrial assets

CapMan Real Estate press release 17 January 2022 at 09:00 AM EET CapMan Nordic Property Income Fund (non-UCITS) acquires a warehouse asset close to Gothenburg further strengthening fund’s exposure to light industrial assets CapMan Nordic Property Income fund (“CMNPI”) has acquired a warehouse asset consisting of two adjacent properties in Mölnlycke Företagspark, Sweden, east of Gothenburg. One of the properties is a fully developed warehouse property of approximately 7,000 square metres which was completed in 2018 and the other one is an undeveloped land plot with

Enhertu granted Priority Review for breast cancer

17 January 2022 07:00 GMT Enhertu granted Priority Review in the US for patients with HER2-positive metastatic breast cancer treated with a prior anti-HER2-based regimen Based on ground-breaking DESTINY-Breast03 results showing AstraZeneca and Daiichi Sankyo's Enhertu reduced the risk of disease progression or death by 72% versus trastuzumab emtansine (T-DM1) Application being evaluated under FDA Real-Time Oncology Review and Project Orbis AstraZeneca and Daiichi Sankyo have received notification of acceptance of the supplemental Biologics License Application (sBLA) of Enhertu (

Heimstaden Encourage Landlords to do Customer Surveys and Publish Results

Unlike many other industries, most landlords are not doing or publishing customer surveys, making it difficult for tenants to compare. Coming from Sweden, where private and public landlords have done this for years, and where media brings attention to the results, we want landlords in the rest of Europe to do the same.“Homes are so important for us all. The more attention landlords get on customer experience and transparency, the more they will focus on improving product and service – beneficial for customers and society. With us doing and sharing results from customer surveys, we increase

Highly satisfactory results from drillings at the Spanish Corcel Project: Estimated 60 million tonnes with 0.25% nickel

Stockholm, 17 January 2022 – Eurobattery Minerals AB (Nordic Growth Market: “BAT” and Börse Stuttgart: “EBM”), a growth company in the mining and exploration industry with the vision to help Europe become self-sufficient in ethical battery minerals, announces that the first assay results have been received from the drill holes carried out as part of the 2021 diamond drilling campaign on its Spanish Project (Corcel Project), initiated in June 2021 and completed on time and on budget. The company believes the results are highly satisfactory for the continued projection of the Corcel resource.

Mycronic receives order for an SLX mask writer

Mycronic AB (publ) has received an order for an SLX mask writer from an existing customer in Asia. The order value is in the range of USD 4-6 million. Delivery of the system is planned for the second quarter of 2022.The SLX laser mask writer meets rising demand for photomasks for the semiconductor industry and a future need for replacement and modernization. Photomasks manufactured by laser mask writers are of high importance and account for 70-75 percent of all photomasks produced for semiconductor manufacturing. SLX is a new and modern mask writer based on the same technology as Mycronic’

MPC Energy Solutions breaks ground on second solar power plant in Colombia

Amsterdam/Oslo – 17 January 2022 – MPC Energy Solutions (MPCES) has commenced construction of Parque Solar Los Girasoles, a solar photovoltaic (PV) plant in Colombia that  will supply around 23 GWh a year – equivalent to the energy consumption of over 17,000 people. MPC Energy Solutions is investing USD 11 million to bring Los Girasoles online, and the project is expected to generate around USD 1.3 million revenues per year once operational. Construction started with Socolco S.A.S.  and commissioning of the solar park is expected in Q4 2022. Solar panels are

Invitation to presentation of Platzer’sYear-end Report for January-December 2021

Platzers Year-end Report for the period January-December 2021 will be published on January 28 at 08.00 CEST. At 09:00 CEST on the same day, investors, analysts, media and other interested parties are invited to participate in a live webcast and teleconference. P-G Persson, CEO, and Fredrik Sjudin, CFO, will present the results for the fourth quarter of 2021. The presentation will be in English and will be followed by a Q&A session. Date:             January 28, 2022Time:            09:00 CESTTo watch the presentation and participate in the teleconference, please use the

Faron to Present at Redeye Fight Cancer Seminar

Faron Pharmaceuticals Ltd. ("Faron") Faron to Present at the Redeye Fight Cancer – Outlook 2022 Seminar Press Release, January 17, 2022 at 02:00 AM (EDT) / 07:00 AM (GMT) / 09:00 AM (EET) TURKU, FINLAND / BOSTON, MA – Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON), a clinical stage biopharmaceutical company focused on building the future of immunotherapy by harnessing the power of the immune system to tackle cancer and inflammation, today announced that Dr. Markku Jalkanen, Chief Executive Officer of Faron, will participate in the Redeye Fight Cancer – Outlook 2022

STENOCARE announces positive outcome of feasibility study

STENOCARE A/SNASDAQ FIRST NORTH GROWTH MARKET, DENMARKTICKER:  STENO STENOCARE A/S (“STENOCARE”) and Solural Pharma (“Solural”) hereby announce that they have reached milestone 1 in the research and development of a new medical cannabis oil formulation, that has the potential to improve the uptake of cannabinoids to be consistent in patients. The milestone is reached in a feasibility study and shows that the Solural Pharma’s Lymphatic Targeting Technology is compatible with full spectrum medical cannabis materials.In December 2019, STENOCARE and Solural announced their partnership to

New interim CFO in InCoax Networks AB

InCoax Networks AB (”InCoax”) has appointed Mats Svensson as new interim CFO. Mats is replacing the current CFO, Emil Bendroth.Mats Svensson has extensive expertise and experience in business controlling, accounting and finance from leading listed and unlisted companies, such as Scan Coin, Imperial Logistics, Flint Group and Nestlé. Mats recently served as Business Controller/Finance Manager at ScanCoin. Emil will assist Mats during a transition period in Q1. ”We welcome Mats to the team in the role of interim CFO. His experience and profile will be an asset to InCoax. We also take the

Stora Enso shares converted

STORA ENSO OYJ STOCK EXCHANGE RELEASE 17 January 2022 at 9.00 EETDuring the 1 December 2021 – 31 December 2021 conversion period there were two conversions and a total of 705 A shares were converted into R shares. The shares were recorded in the Finnish trade register today, 17 January 2022, and trading in the new R shares will start on 18 January 2022.Breakdown of shares after conversion: A shares 176,243,344R shares 612,376,643Total 788,619,987 Each A share and each ten R shares carry one vote. The total amount of votes after the conversion is at least 237,481,008.For

What is Glashütte?

Virtually everyone has heard the name, perhaps fewer think they can pronounce it correctly, but how many actually know what it is? In short, it’s the destination for people in love with watches, and a hub for the finest products Made in Germany which celebrates its birthday: 175 years of watchmaking.GLASHÜTTE, JANUARY 2022. In Germany, there are over 30 towns called Glashütte—more are scattered across Eastern Europe, Austria, Switzerland, and America. However, only one Glashütte is celebrating the 175th birthday of watchmaking heritage: The small town of Glashütte, nestled between the

A major project brings together Finnish industry and research for quantum technology development

Press release 17 January 2022 A new research project has been launched to accelerate the progress of Finnish quantum technology. The QuTI project, coordinated by VTT Technical Research Centre of Finland, will develop new components, manufacturing and testing solutions and algorithms for the needs of quantum technology. The QuTI consortium, partly financed by Business Finland, consists of 12 partners and has a total budget of around EUR 10 million.Quantum technology is developing into a widespread field in industry. This quantum wave is motivated by the unprecedented performance

Wihlborgs builds new premises for Doka Sweden in Helsingborg

Wihlborgs has signed an agreement with Doka Sverige AB for new construction of a facility spanning 2,200 m² at Snårskogen 5 in north Väla in Helsingborg. The facility, which is scheduled for occupancy in the beginning of 2023, will house warehouses and offices for business operations in southern Sweden.Doka Sverige AB is a wholly owned subsidiary of Doka GmbH with its registered office in Austria. Doka GmbH develops, manufactures, sells and rents formwork systems that are used for all types of cast in situ concrete constructions. The company is one of the two global leaders within this

Storskogen UK acquires Tornado Group

Storskogen continues its international expansion with its third acquisition in UK after taking a qualified majority stake in Tornado Group Ltd. Tornado Group is a leading provider of premium branded animal fencing products, with an annual revenue and EBIT of approximately GBP 34.7m and GBP 5.2m, respectively for the last twelve month period ended on 30 November 2021.Since its establishment in 1969, Tornado has gone from its humble beginnings to become a name synonymous with quality in animal fence manufacturing. The development has been underpinned by the company’s innovative approach which

ADDvise signs Letter of Intent to acquire Surplus Diabetic, Inc.

ADDvise Group AB (publ) has signed a Letter of Intent with the shareholders of Surplus Diabetic, Inc. (”Surplus Diabetic”) regarding an acquisition of 100 percent of the shares in Surplus Diabetic. Surplus Diabetic is an American medtech company, specialized in supplying the U.S. market with diabetes products, such as glucose monitors, insulin and test stripes. Sales are made to pharmacies, wholesalers and directly to consumers. Surplus Diabetic is based in Deerfield Beach, Florida. The revenue for the last twelve months as of November 30, 2021, amounted to approximately USD 18.1

There are no items matching the current filter
There are no more items matching the current filter
Back to top